logo
Select company
Select metric
$ 9.91MNet Cash Flow - Financing
VS
Market
33
Sector
43
Industry
52
History
67
$ 3.04Close
$ 0.9 - $ 6.06 52-Week Range
Ticker Information

Ticker

ALEC

Company Name

ALECTOR INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALECTOR INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ALEC - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 9.91M
3/31/2025$ 10.43M
12/31/2024$ 81.54M
9/30/2024$ 72.34M
6/30/2024$ 72.34M
3/31/2024$ 72.58M
12/31/2023$ 2.55M
9/30/2023$ 2.6M
6/30/2023$ 3.08M
3/31/2023$ 3.11M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ALECTOR INC's latest trailing twelve months (TTM) CF - Financing stands at $ 232.45M.
  • Over the past 5 years, ALECTOR INC's average CF - Financing has been $ 46.83M.
  • The median CF - Financing for ALECTOR INC during this period was $ 17.63M
  • ALECTOR INC reached its highest CF - Financing over the past 5 years at $ 232.45M.
  • The lowest CF - Financing recorded by ALECTOR INC in the same timeframe $ 2.55M

ALECTOR INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
SGMO : SANGAMO THERAPEUTICS INC $ 43.54MBDTX : BLACK DIAMOND THERAPEUTICS INC $ -45KTHTX : THERATECHNOLOGIES INC $ -16.64MENTA : ENANTA PHARMACEUTICALS INC $ -25.51MAGEN : AGENUS INC $ 43.46MPLX : PROTALIX BIOTHERAPEUTICS INC $ -7.61MSPRO : SPERO THERAPEUTICS INC $ 0CSBR : CHAMPIONS ONCOLOGY INC $ 193KTRDA : ENTRADA THERAPEUTICS INC $ 2.08MCELU : CELULARITY INC $ 4.51M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

ALEC - Net Cash Flow - Financing, Last 5 years

$ 2.55M

Minimum

Dec 31, 2023

$ 232.45M

Maximum

Sep 30, 2020

$ 46.83M

Average

$ 17.63M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M